Sol-Millennium Medical Inc. Launches U.S. B2B eShop, Providing Direct Access to Safety Engineered Medical Devices Nationwide

Key Takeaways

• U.S. B2B e‑shop launched for direct purchasing
• Customer base grew 131% in nine months
• Over 16,000 U.S. healthcare customers now served
• Products cover diabetes, medication delivery, diagnostics, and more
• Platform aims to reduce procurement time for clinicians

Summary

Sol‑Millennium Medical Inc. has launched a dedicated U.S. B2B e‑commerce platform, b2b.solm.com, allowing healthcare providers nationwide to purchase its safety‑engineered medical devices directly. The site streamlines registration, pricing visibility, and order placement for settings ranging from physician offices to veterinary clinics. The company now supports more than 16,000 U.S. customers, with a 131% increase in its customer base over the past nine months, and offers over 1,400 products across ten categories. CEO Liang Lin says the platform will free clinicians from supply‑management tasks, letting them focus on patient care.

Pulse Analysis

The U.S. medical‑device market has long relied on multi‑layered distribution networks that add cost and delay. Recent shifts toward digital procurement are reshaping how hospitals, clinics, and even veterinary practices source supplies. By offering a single‑click storefront, Sol‑Millennium’s b2b.solm.com aligns with this trend, giving buyers immediate pricing, inventory transparency, and the ability to place orders of any size without intermediary negotiations.

Sol‑Millennium’s portfolio distinguishes itself through safety‑engineered design, a priority that resonates with providers facing stringent regulatory and infection‑control standards. From safety insulin syringes to IV catheters and protective apparel, each product line is backed by the company’s Swiss‑based R&D hub and global manufacturing partnerships. The e‑shop aggregates these offerings, allowing clinicians to consolidate orders, reduce stock‑outs, and standardize device usage across departments, ultimately improving workflow efficiency and patient outcomes.

Growth metrics underscore the platform’s market traction: a 131% surge in U.S. customers, more than 16,000 active accounts, and support for over 13 million patients through blood‑collection devices alone. This rapid adoption signals that providers value both the safety focus and the streamlined purchasing experience. As the platform scales, Sol‑Millennium is positioned to capture greater share of the fragmented supply chain, potentially setting a new benchmark for direct‑to‑provider medical‑device commerce in the United States.